GRACE KEIM: Open Payments
NPI 1073996823 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 7 payments from 5 companies in 2025. Trend: 2023 $427 · 2024 $483 · 2025 $481
Food & beverage: $355Education: $126
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $151 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| SEAGEN INC. | 1 | $100 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: ELREXFIO, LYNPARZA, TIVDAK, KEYTRUDA.
Industry payments across WA — which companies pay providers there.
